Flt-3 Ligand Reverses Late Allergic Response and Airway Hyper-Responsiveness in a Mouse Model of Allergic Inflammation

Journal of Immunology

Volumn 172, Issue 8, 2004, Pages 5016-5023

  Edwan, Jehad H ^a   Perry, Greg ^a   Talmadge, James E ^b   Agrawal, Devendra K ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CYTOKINE; FLT3 LIGAND; GLYCOPROTEIN P 15095; INTERLEUKIN 12; INTERLEUKIN 4; INTERLEUKIN 5; METHACHOLINE; OVALBUMIN; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC DISEASE; ALLERGIC REACTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHUS HYPERREACTIVITY; CELL COUNT; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DISEASE MODEL; EOSINOPHIL; FEMALE; INFLAMMATION; LUNG FUNCTION; LUNG LAVAGE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 1842529164     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.172.8.5016     Document Type: Article

References (70)

1. Busse, W. W., and R. F. Lemanske, Jr. 2001. Asthma. N. Engl. J. Med. 344:350.
2. Hopfenspirger, M. T., S. K. Parr, R. J. Hopp, R. G. Townley, and D. K. Agrawal. 2001. Mycobacterial antigens attenuate late phase response, airway hyperresponsiveness, and bronchoalveolar lavage eosinophilia in a mouse model of bronchial asthma. Int. Immunopharmacol. 1:1743.
3. Janssen, E. M., A. J. van Oosterhout, A. J. van Rensen, W. van Eden, F. P. Nijkamp, and M. H. Wauben. 2000. Modulation of Th2 responses by peptide analogues in a murine model of allergic asthma: amelioration or deterioration of the disease process depends on the Th1 or Th2 skewing characteristics of the therapeutic peptide. J. Immunol. 164:580.
4. Kato, Y., T. Manabe, Y. Tanaka, and H. Mochizuki. 1999. Effect of an orally active Th1/Th2 balance modulator, M50367, on IgE production, eosinophilia, and airway hyperresponsiveness in mice. J. Immunol. 162:7470.
5. Michael, T. H., K. P. Sharidan, G. T. Robert, and K. A. Devendra. 2002. Attenuation of allergic airway inflammation and associated pulmonary functions by mycobacterial antigens is independent of IgE in a mouse model of asthma. Allergol. Int. 51:21.
6. Tomkinson, A., C. Duez, G. Cieslewicz, J. C. Pratt, A. Joetham, M. C. Shanafelt, R. Gundel, and E. W. Gelfand. 2001. A murine IL-4 receptor antagonist that inhibits IL-4- and IL-13-induced responses prevents antigen-induced airway eosinophilia and airway hyperresponsiveness. J. Immunol. 166:5792.
7. Zuany-Amorim, C., S. Haile, D. Leduc, C. Dumarey, M. Huerre, B. B. Vargaftig, and M. Pretolani. 1995. Interleukin-10 inhibits antigen-induced cellular recruitment into the airways of sensitized mice. J. Clin. Invest. 95:2644.
8. Erb, K. J. 1999. Atopic disorders: a default pathway in the absence of infection? Immunol. Today 20:317.
9. von Hertzen, L. C., and T. Haahtela. 2000. Could the risk of asthma and atopy be reduced by a vaccine that induces a strong T-helper type I response? Am. J. Respir. Cell Mol. Biol. 22:139.
10. O'Garra, A., and K. Murphy. 1994. Role of cytokines in determining T-lymphocyte function. Curr. Opin. Immunol. 6:4586.
11. Johansson, S. G., T. Haahtela, and P. M. O'Byrne. 2002. Omalizumab and the immune system: an overview of preclinical and clinical data. Ann. Allergy Asthma Immunol. 89:132.
12. Mauser, P. J., A. M. Pitman, X. Fernandez, S. K. Foran, G. K. Adams III, W. Kreutner, R. W. Egan, and R. W. Chapman. 1995. Effects of an antibody to interleukin-5 in a monkey model of asthma. Am. J. Respir. Crit. Care Med. 152:467.
13. Cheng, G., M. Arima, K. Honda, H. Hirata, F. Eda, N. Yoshida, F. Fukushima, Y. Ishii, and T. Fukuda. 2002. Anti-interleukin-9 antibody treatment inhibits airway inflammation and hyperreactivity in mouse asthma model. Am. J. Respir. Crit Care Med. 166:409.
14. Isolauri, E., T. Arvola, Y. Sutas, E. Moilanen, and S. Salminen. 2000. Probiotics in the management of atopic eczema. Clin. Exp. Allergy 30:1604.
15. Krieg, A. M. 2002. CpG motifs in bacterial DNA and their immune effects. Annu. Rev. Immunol. 20:709.
16. Kandimalla, E. R., D. Yu, Q. Zhao, and S. Agrawal. 2001. Effect of chemical modifications of cytosine and guanine in a CpG-motif of oligonucleotides: structure-immunostimulatory activity relationships. Bioorg. Med. Chem. 9:807.
17. Nahori, M. A., M. Lagranderie, J. Lefort, F. Thouron, D. Joseph, N. Winter, B. Gicquel, J. R. Lapa e Silva, and B. B. Vargaftig. 2001. Effects of Mycobacterium bovis BCG on the development of allergic inflammation and bronchial hyperresponsiveness in hyper-IgE BP2 mice vaccinated as newborns. Vaccine 19:1484.
18. Hopfenspirger, M. T., and D. K. Agrawal. 2002. Airway hyperresponsiveness, late allergic response, and eosinophilia are reversed with mycobacterial antigens in ovalbumin-presensitized mice. J. Immunol. 168:2516.
19. Aaby, P., S. O. Shaheen, C. B. Heyes, A. Goudiaby, A. J. Hall, A. W. Shiell, H. Jensen, and A. Marchant. 2000. Early BCG vaccination and reduction in atopy in Guinea-Bissau. Clin. Exp. Allergy 30:644.
20. Shirakawa, T., T. Enomoto, S. Shimazu, and J. M. Hopkin. 1997. The inverse association between tuberculin responses and atopic disorder. Science 275:77.
21. Abou-Rebyeh, H., H. Naher, and H. Hahn. 1992. Delayed type hypersensitivity (DTH): quantitative studies of mycobacteria-induced destructive and non-destructive DTH-reactions in the skin of guinea pigs. Zentralbl. Bakteriol. 276:398.
22. Wang, L., M. O. Turner, R. K. Elwood, M. Schulzer, and J. M. FitzGerald. 2002. A meta-analysis of the effect of bacille Calmette Guérin vaccination on tuberculin skin test measurements. Thorax 57:804.
23. Barnes, P. J. 2002. Cytokine modulators as novel therapies for asthma. Annu. Rev. Pharmacol. Toxicol. 42:81.
24. Lyman, S. D., L. James, L. Johnson, K. Brasel, P. de Vries, S. S. Escobar, H. Downey, R. R. Splett, M. P. Beckmann, and H. J. McKenna. 1994. Cloning of the human homologue of the murine flt3 ligand: a growth factor for early hematopoietic progenitor cells. Blood 83:2795.
25. + human bone marrow cells and is involved in the proliferation of early progenitor/stem cells. Proc. Natl. Acad. Sci. USA 91:459.
26. Robinson, S., R. L. Mosley, P. Parajuli, V. Pisarev, J. Sublet, A. Ulrich, and J. Talmadge. 2000. Comparison of the hematopoietic activity of flt-3 ligand and granulocyte-macrophage colony-stimulating factor acting alone or in combination. J. Hematother. Stem Cell Res. 9:711.
27. Pulendran, B., J. Banchereau, S. Burkeholder, E. Kraus, E. Guinet, C. Chalouni, D. Caron, C. Maliszewski, J. Davoust, J. Fay, et al. 2000. Flt3-ligand and granulocyte colony-stimulating factor mobilize distinct human dendritic cell subsets in vivo. J. Immunol. 165:566.
28. Maraskovsky, E., K. Brasel, M. Teepe, E. R. Roux, S. D. Lyman, K. Shortman, and H. J. McKenna. 1996. Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified. J. Exp. Med. 184:1953.
29. Maraskovsky, E., B. Pulendran, K. Brasel, M. Teepe, E. R. Roux, K. Shortman, S. D. Lyman, and H. J. McKenna. 1997. Dramatic numerical increase of functionally mature dendritic cells in FLT3 ligand-treated mice. Adv. Exp. Med Biol. 417:33.
30. Pulendran, B., J. L. Smith, G. Caspary, K. Brasel, D. Pettit, E. Maraskovsky, and C. R. Maliszewski. 1999. Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proc. Natl. Acad. Sci. USA 96:1036.
31. Fong, L., Y. Hou, A. Rivas, C. Benike, A. Yuen, G. A. Fisher, M. M. Davis, and E. G. Engleman. 2001. Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy. Proc. Natl. Acad. Sci. USA 98:8809.
32. Antonysamy, M. A., and A. W. Thomson. 2000. Flt3 ligand (FL) and its influence on immune reactivity. Cytokine 12:87.
33. +) dendritic cells: association with conversion from liver transplant tolerance to acute rejection. Transplantation 69:2647.
34. + progenitor cells isolated from healthy donor blood; growth factor combination determines proliferation rate and functional outcome. J. Leukocyte Biol. 72:321.
35. O'Garra, A. 1998. Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity 8:275.
36. Agrawal, D. K., M. T. Hopfenspirger, J. Chavez, and J. E. Talmadge. 2001. Flt3 ligand: a novel cytokine prevents allergic asthma in a mouse model. Int. Immunopharmacol. 1:2081.
37. Hamelmann, E., J. Schwarze, K. Takeda, A. Oshiba, G. L. Larsen, C. G. Irvin, and E. W. Gelfand. 1997. Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am. J. Respir. Crit Care Med. 156:766.
38. Chong, B. T., D. K. Agrawal, F. A. Romero, and R. G. Townley. 1998. Measurement of bronchoconstriction using whole-body plethysmograph: comparison of freely moving versus restrained guinea pigs. J. Pharmacol. Toxicol. Methods 39:163.
39. Dohi, M., S. Tsukamoto, T. Nagahori, K. Shinagawa, K. Saitoh, Y. Tanaka, S. Kobayashi, R. Tanaka, Y. To, and K. Yamamoto. 1999. Noninvasive system for evaluating the allergen-specific airway response in a murine model of asthma. Lab. Invest. 79:1559.
40. Saloga, J., H. Renz, G. Lack, K. L. Bradley, J. L. Greenstein, G. Larsen, and E. W. Gelfand. 1993. Development and transfer of immediate cutaneous hypersensitivity in mice exposed to aerosolized antigen. J. Clin. Invest. 91:133.
41. H2-type cells or with elevated concentrations of histamine or cicosanoids in bronchoalveolar fluid. J. Allergy Clin. Immunol. 108:394.
42. Walker, C., E. Bode, L. Boer, T. T. Hansel, K. Blaser, and J. C. Virchow, Jr. 1992. Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage. Am. Rev. Respir. Dis. 146:109.
43. Robinson, D. S., Q. Hamid, S. Ying, A. Tsicopoulos, J. Barkans, A. M. Bentley, C. Corrigan, S. R. Durham, and A. B. Kay. 1992. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N. Engl. J. Med. 326:298.
44. Robinson, D. S., Q. Hamid, M. Jacobson, S. Ying, A. B. Kay, and S. R. Durham. 1993. Evidence for Th2-type T helper cell control of allergic disease in vivo. Springer Semin. Immunopathol. 15:17.
45. Brusselle, G., J. Kips, G. Joos, H. Bluethmann, and R. Pauwels. 1995. Allergen-induced airway inflammation and bronchial responsiveness in wild-type and interleukin-4-deficient mice. Am. J. Respir. Cell Mol. Biol. 12:254.
46. Brusselle, G. G., J. C. Kips, J. H. Tavernier, J. G. van der Heyden, C. A. Cuvelier, R. A. Pauwels, and H. Bluethmann. 1994. Attenuation of allergic airway inflammation in IL-4 deficient mice, Clin. Exp. Allergy. 24:73.
47. + T cells to a "Th2-like" phenotype: a link between viral infections and bronchial asthma. Ann. NY Acad. Sci. 796:97.
48. Venkayya, R., M. Lam, M. Willkom, G. Grunig, D. B. Corry, and D. J. Erle. 2002. The Th2 lymphocyte products IL-4 and IL-13 rapidly induce airway hyperresponsiveness through direct effects on resident airway cells. Am. J. Respir. Cell Mol. Biol. 26:202.
49. Kips, J. C., G. G. Brusselle, G. F. Joos, R. A. Peleman, R. R. Devos, J. H. Tavernier, and R. A. Pauwels. 1995. Importance of interleukin-4 and interleukin-12 in allergen-induced airway changes in mice. Int. Arch. Allergy Immunol. 107:115.
50. Peng, Z., H. Wang, X. Mao, K. T. HayGlass, and F. E. Simons. 2001. CpG oligodeoxynucleotide vaccination suppresses IgE induction but may fail to down-regulate ongoing IgE responses in mice. Int. Immunol. 13:3.
51. Hogan, S. P., A. Mould, H. Kikutani, A. J. Ramsay, and P. S. Foster. 1997. Aeroallergen-induced eosinophilic inflammation, lung damage, and airways hyperreactivity in mice can occur independently of IL-4 and allergen-specific immunoglobulins. J. Clin. Invest. 99:1329.
52. Wilder, J. A., D. D. Collie, B. S. Wilson, D. E. Bice, C. R. Lyons, and M. F. Lipscomb. 1999. Dissociation of airway hyperresponsiveness from immunoglobulin E and airway eosinophilia in a murine model of allergic asthma. Am. J. Respir. Cell Mol. Biol. 20:1326.
53. Yeung, V. P., R. S. Gieni, D. T. Umetsu, and R. H. DeKruyff. 1998. Heat-killed Listeria monocytogenes as an adjuvant converts established murine Th2-dominated immune responses into Th1-dominated responses. J. Immunol. 161:4146.
54. Finkelman, F. D., I. M. Katona, T. R. Mosmann, and R. L. Coffman. 1988. IFN-γ regulates the isotypes of Ig secreted during in vivo humoral immune responses. J. Immunol. 140:1022.
55. Snapper, C. M., C. Peschel, and W. E. Paul. 1988. IFN-γ stimulates IgG2a secretion by murine B cells stimulated with bacterial lipopolysaccharide. J. Immunol. 140:2121.
56. Nakagawa, T. 1988. Egg white-specific IgE and IgG subclass antibodies and their associations with clinical egg hypersensitivity. N. Engl. Reg Allergy Proc. 9:67.
57. Baca-Estrada, M. E., C. Ewen, D. Mahony, L. A. Babiuk, D. Wilkie, and M. Foldvari. 2002. The haemopoietic growth factor, Flt3L, alters the immune response induced by transcutaneous immunization. Immunology. 107:69.
58. Pabst, R., A. Luhrmann, I. Steinmetz, and T. Tschernig. 2003. A single intratracheal dose of the growth factor Fms-like tyrosine kinase receptor-3 ligand induces a rapid differential increase of dendritic cells and lymphocyte subsets in lung tissue and bronchoalveolar lavage, resulting in an increased local antibody production. J. Immunol. 171:325.
59. Pulendran, B., J. Lingappa, M. K. Kennedy, J. Smith, M. Teepe, A. Rudensky, C. R. Maliszewski, and E. Maraskovsky. 1997. Developmental pathways of dendritic cells in vivo: distinct function, phenotype, and localization of dendritic cell subsets in FLT3 ligand-treated mice. J. Immunol. 159:2222.
60. Moser, M., and K. M. Murphy. 2000. Dendritic cell regulation of TH1-TH2 development. Nat. Immunol. 1:199.
61. D'Amico, A., and L. Wu. 2003. The early progenitors of mouse dendritic cells and plasmacytoid predendritic cells are within the bone marrow hemopoietic precursors expressing Flt3. J. Exp. Med. 198:293.
62. Jefford, M., M. Schnurr, T. Toy, K. A. Masterman, A. Shin, T. Beecroft, T. Y. Tai, K. Shortman, M. Shackleton, I. D. Davis, et al. 2003. Functional comparison of DCs generated in vivo with Flt3 ligand or in vitro from blood monocytes: differential regulation of function by specific classes of physiologic stimuli. Blood 102:1753.
63. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392:245.
64. Steinman, R. M., S. Turley, I. Mellman, and K. Inaba. 2000. The induction of tolerance by dendritic cells that have captured apoptotic cells. J. Exp. Med. 191:411.
65. Wakkach, A., N. Fournier, V. Brun, J. P. Breittmayer, F. Cottrez, and H. Groux. 2003. Characterization of dendritic cells that induce tolerance and T regulatory I cell differentiation in vivo. Immunity 18:605.
66. Buelens, C., V. Verhasselt, D. De Groote, K. Thielemans, M. Goldman, and F. Willems. 1997. Human dendritic cell responses to lipopolysaccharide and CD40 ligation are differentially regulated by interleukin-10. Eur. J. Immunol. 27:1848.
67. Corinti, S., C. Albanesi, A. la Sala, S. Pastore, and G. Girolomoni. 2001. Regulatory activity of autocrine IL-10 on dendritic cell functions. J. Immunol. 166:4312.
68. Faria, A. M., R. Maron, S. M. Ficker, A. J. Slavin, T. Spahn, and H. L. Weiner. 2003. Oral tolerance induced by continuous feeding: enhanced up-regulation of transforming growth factor-β/interleukin-10 and suppression of experimental autoimmune encephalomyelitis. J. Autoimmun. 20:135.
69. + T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J. Exp. Med. 192:1213.
70. + T cells with regulatory properties isolated from peripheral blood. J. Exp. Med. 193:1285.